3Tikhomirov E. WHO program for the control of hospital infec- tions[J]. Chemiotherapia, 1987, 6(3) : 148 - 151.
4Elixhauser A, Steiner C. Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U. S. Hospitals, 1993 - 2005[EB/OL]. http://www, hcup-us, ahrq. gov/reports/stat briefs/sb35, pdf ,2007 - 07.
5Boyce J M. Environmental contamination makes an important contribution to hospital infeetion[J]. J Hosp Infect ,2007, 65 (Suppl 2) : 50 - 54.
6Hayden M K, Blom D W, Lyle E A, et al. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients" en- vironment[J]. Infect Control Hosp Epidemiol, 2008, 29(2): 149- 154.
7Huang S S, Datta R, Platt R, et al. Risk of acquiring antibi- otic-resistant bacteria from prior room occupants[J]. Arch In- tern Med, 2006, 166(18):1945- 1951.
8Goodman E R, Platt R, Bass R, et al. Impact of an environ- mental cleaning intervention on the presence of methicillin-re- sistant Staphylococcus aureus and vancomycin-resistant en- terococci on surfaces in intensive care unit rooms [J]. Infect Control Hosp Epidemiol,2008, 29(7) :593 - 599.
9Elixhauser A, Jhung M. Clostridium difficile-associated dis- ease in U.S. hospitals, 1993 - 2005[EB/OL]. http..//www. hcup-us, ahrq. gov/reports/statbriefs/sbS0, pdf, 2008 - 04.
10Kaatz G W, Gitlin S D, Schaberg D R, et al. Acquisition of Clostridium difficile from the hospital environment[J]. AmJ Epidemiol, 198B, 127(6) :1289- 1294.
